Ιατρική Σχολή / Medical School: Recent submissions
Now showing items 281-300 of 1246
-
Article
Metastatic breast cancer with liver metastases: A registry analysis of clinicopathologic, management and outcome characteristics of 500 women
(2006)Introduction. Breast cancer patients developing liver metastases have traditionally been considered to make up a poor prognosis group with median survival rates of less than 6 months. We retrospectively analysed clinicopathologic ...
-
Article
-
Article
The role of chemotherapy in non-small cell lung cancer. A retrospective analysis of 100 patients
(1990)
-
Article
Oncology for medical students:. A European School of Oncology contribution to undergraduate cancer education
(2007)Worldwide undergraduate cancer medicine is taught in a non-unanimous manner. There are frequent overlaps, omissions and discrepancies in the curricula of different medical schools concerning oncology teaching. Various ...
-
Article
The clinical picture of primary Sjogren's syndrome: A retrospective study
(1982)The clinical and laboratory features of 47 patients with primary Sjogren's syndrome, confirmed by lip biopsy, were analyzed in this study. The majority of our patients had the classical signs and symptoms of Sjogren's ...
-
Article
Euro-Arab School of Oncology: an educational collaborative activity of the European School of Oncology with the Arab world
(2011)In this article, we report on the new endeavor of the European School of Oncology to offer collaborative educational activity to the Arab oncologists. We present the 4-year detailed programme held in different Middle East ...
-
Article
Clear‐cell sarcoma of tendons and aponeuroses: A clinicopathologic study. Presentation of six additional cases with review of the literature
(1984)Clear‐cell sarcoma of tendons and aponeuroses is a rare and slowly growing soft tissue sarcoma, affecting mainly young adults. During the last 15 years, approximately 60 cases have been reported in the literature. In this ...
-
Article
A randomized phase II study with two schedules of the novel indoloquinone EO9 in non-small-cell lung cancer: A study of the EORTC early clinical studies group (ECSG)
(1996)In a multicentre randomized trial of the EORTC-ECSG, we have treated 38 chemotherapy naive patients with advanced non-small-cell lung cancer (NSCLC) with EO9, a novel bioreductive alkylating indoloquinone. The drug was ...
-
Article
Is androgen substitution necessary in hypogonadal patients when they are treated with chemotherapy for malignant diseases?
(1989)A patient with hypogonadotropic hypogonadism owing to endogenous gonadotropin releasing hormone deficiency, who developed Hodgkin's disease is described. Chemotherapy administration caused prolonged and life‐threatening ...
-
Article
-
Article
Primary lymphoma of the pericardium: Report on a 'cured' case and review of the literature
(1994)This report describes a 62-year-old man with a primary diffuse, immunohistochemically proven B-cell lymphoma of large noncleaved cell (centroblastic) type of the pericardium. The patient responded completely to systemic ...
-
Article
Evaluation of six tumor markers in patients with carcinoma of unknown primary
(1994)We have retrospectively evaluated six serum tumor markers in 85 patients with carcinoma of unknown primary. The serum levels of carcinoembryonic antigen (CEA), CA 19‐9, CA 15‐3, CA 125, β‐chorionic gonadotropin (β‐HCG) and ...
-
Article
A successfully treated case of multicentric angiofollicular hyperplasia with oral chemotherapy (Castleman's disease)
(1990)A case of angiofollicular lymph node hyperplasia of plasma cell type in a 60‐year‐old woman is reported. The patient presented with lymphadenopathy, splenomegaly, and fever. She responded dramatically to chlorambucil and ...
-
Article
Carzelesin phase II study in advanced breast, ovarian, colorectal, gastric, head and neck cancer, non-Hodgkin's lymphoma and malignant melanoma: A study of the EORTC early clinical studies group (ECSG)
(2000)Purpose: In a phase II trial, the activity of carzelesin, a cyclopropylpyrroloindole prodrug analog, was assessed. Patients and methods: Carzelesin was used as second- or third-line chemotherapy in patients with breast, ...
-
Article
A Phase II trial of carboplatin and vindesine in patients with non-small cell lung cancer. A Hellenic Cooperative Oncology Group study
(1993)In an effort to investigate a regimen less toxic and more convenient than cisplatin combinations, 50 patients with non-small cell lung cancer (NSCLC) were treated in a Phase II study with carboplatin and vindesine. Carboplatin ...
-
Article
The Masterclass of the European School of Oncology: The 'key educational event' of the school
(2010)The European School of Oncology (ESO) Clinical Masterclass is a one-week, full-immersion course, where students and teachers intensively interact with each other. This educational event is designed for medical or clinical ...
-
Article
Diagnostic and therapeutic management of cancer of an unknown primary
(2003)Metastatic Cancer of Unknown Primary Site (CUP) accounts for approximately 3% of all malignant neoplasms and is therefore one of the 10 most frequent cancer diagnoses in man. Patients with CUP present with metastatic disease ...
-
Article
-
Article
-
Article